Anurag Maheshwari, M.D., specializes in liver disease at The Center for Liver and Hepatobiliary Diseases, part of The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy in Baltimore, Maryland. His expertise helps patients seeking focused care for medical conditions of the liver. Dr. Anurag Maheshwari provides experience in treating a range of concerns involving the liver including hepatitis, liver cancer, cirrhosis and bile duct conditions. Dr. Maheshwari cares for patients in need of liver transplants and assists in pre- and post-operative transplant medical care, providing each patient individualized attention, coordination with liver transplant centers, and understanding as they progress toward recovery. Working with international authority Dr. Paul Thuluvath, Dr. Anurag Maheshwari is one of the physicians of The Institute for Digestive Health & Liver Disease at Mercy leading the way in the diagnosis and treatment of liver diseases. Dr. Anurag Maheshwari works collaboratively with the specialists of The Institute for Cancer Care at Mercy, The Center for Minimally Invasive Surgery at Mercy, The Center for Interventional Pain Medicine at Mercy, The Lung Center at Mercy, and the Division of Interventional Radiology. This comprehensive approach to diagnosis and treatment of digestive tract diseases and the expertise of our doctors makes The Institute for Digestive Health & Liver Disease at Mercy one of the best in Baltimore and the Mid-Atlantic region. Dr. Maheshwari has been named a "Top Doctor" in Gastroenterology/Liver Disease by Baltimore magazine. Dr. Anurag Maheshwari is active in advanced research projects in liver diseases. He has authored many peer-reviewed publications and book chapters on issues in liver disease. Dr. Anurag Maheshwari is an active speaker and has appeared at conferences and hospital grand rounds around the country. He has been published in: American Journal of Gastroenterology Digestive Diseases and Sciences Gastroenterology Hepatology Lancet Liver Transplantation Shakelford’s Surgery of the Alimentary Tract
Armando Sardi, M.D., is a respected and renowned Surgical Oncologist who has been honored as a Top Doc in Baltimore magazine multiple times. He serves as Medical Director of The Institute for Cancer Care at Mercy and as Chief of Division of Surgical Oncology at Mercy Medical Center in Downtown Baltimore, Maryland. Dr. Sardi is one of Maryland’s leading surgical oncologists who use Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late-stage, complex cancers of the abdominal region. Dr. Sardi has been performing HIPEC procedures since 1994 and is considered to be among the best doctors using the technique. This advanced heated chemotherapy procedure is often a life-saving treatment option for patients who have exhausted more traditional treatment plans for stomach cancer. Patients have traveled to Mercy Medical Center from points up and down the East Coast to destinations across the U.S., to seek out Dr. Sardi for his cancer expertise in the HIPEC treatment. Dr. Armando Sardi is a man whose professional focus is devoted to medical excellence, research and finding a cure for cancer. For his patients, Dr. Sardi’s personal concern and approach to their care are what helps them gain a positive outlook and confidence to face the challenges ahead. His cheerful smile and kind-hearted laugh immediately put patients at ease. And yet, his unyielding determination to give every patient the best possible chance to overcome their illness that ranks him among the best of the best. When other doctors have told patients there is no hope, Dr. Sardi tries even harder to beat the odds. Thanks to Dr. Sardi, the HIPEC procedure and other leading-edge treatment options, he has given patients so much more than hope. Patient after patient, year after year, have shared their stories at Mercy’s National Cancer Day Survivor Celebration and Mercy's annual Heat It to Beat It fundraising event. There are 3, 5, 10-year cancer survivors – each telling a heartwarming story of hope and survivorship. Dr. Sardi co-chair Mercy’s Cancer Committee and actively participates in The Tumor Board. These efforts allow cancer experts, specialists and key members of the healthcare team to discuss and collaborate on complex cancer cases to learn new and different ways to optimize resources, medical knowledge and treat patients so that long-term results will be improved. Dr. Sardi also plays a key role in the Mercy National Cancer Survivor Day festivities. This joyous and spirited celebration is more than a reunion of cancer survivors, it is a day when Dr. Sardi and the Mercy family rejoice with their patients and loved ones. Together they have been through a long and challenging cancer journey and together they delight in all the possibilities ahead. Dr. Armando Sardi, whose celebrated reputation has garnered local and international acclaim, has earned an international reputation for the advances he has made in the surgical oncology field and for his humanitarian efforts to care for the poor and underserved in third world countries. Dr. Sardi has been distinguished in Colombia, South America as one of the 100 Most Influential Expatriates – an honor received, in part, for the medical care he provides through the non-profit organization, Partners for Cancer Care and Prevention. This organization was the recipient of the Conquer Cancer Foundation's Inaugural International Innovation Grant. Dr. Armando Sardi has been recognized for his research, leadership and compassionate bedside manner. Some of his awards include: “Hispanic Hero Award for Excellence as a Medical/Social Entrepreneur” Presented by USHYEE “Gold Star Teamwork Award” Presented by The Sisters of Mercy in recognition of Gold Star performance Honored by Fusionarte as one of “100 Colombianos” who represent the talent, creativity, and perseverance of Colombia. Bogota, Colombia December 2012 Named by Baltimore Magazine a "Top Doctor" in the Surgical Oncology specialty Named by Castle Connelly Medical Ltd. a "Top Doctor" in Surgery Dr. Sardi founded the annual HEAT IT TO BEAT IT benefit walk in Baltimore to raise awareness about HIPEC and cancer treatment.
Bernard (Bernie) W. Chang, M.D., Director of Baltimore’s Plastic & Reconstructive Surgery at Mercy, also leads The Breast Reconstruction and Restoration Center at Mercy. Dr. Bernie Chang is Board Certified in Plastic Surgery and General Surgery. He pioneered and advanced surgical treatment options like DIEP flap surgery for breast reconstruction. With a skilled and highly specialized team of doctors, Mercy's Plastic Surgery and Breast Reconstruction Centers are known as one of the Mid-Atlantic’s best in breast reconstruction and restoration, cosmetic medicine and plastic surgery. As the Assistant Director of The Hoffberger Breast Center at Mercy in Baltimore, Dr. Bernie Chang works closely with the Breast Center doctors to provide seamless care for those women who choose immediate breast reconstruction after breast surgery. The industry-leading expertise of Dr. Chang and the renowned reputation of the physicians of The Breast Center result in choices that women may not find elsewhere. With more than 20 years of medical experience, Dr. Chang offers women peace of mind in breast reconstruction and restoration. His quiet thoughtfulness and attention to the needs of his patients provide a calming touch that helps each woman focus on her treatment options and recovery. His expertise is in helping women reclaim their feminine form and personal self-esteem after a diagnosis and treatment for breast cancer. Women say they have regained their physical and emotional balance in the care of Dr. Chang. Dr. Chang has performed DIEP flap breast reconstruction surgery for decades and his leadership is widely known. DIEP flap breast reconstruction surgery is one of the most widely performed breast shaping options for women. Dr. Chang is also skilled in other microsurgical flap procedures including: DIEP flap SGAP flap & Bilateral SGAP Flap IGAP flap TUG flap Latissimus flap Dr. Bernie Chang’s surgical expertise attracts surgical fellows from across the nation to train in the renowned Fellowship Program at Mercy in breast reconstruction and surgical flap treatment options.
Bonni Lee Guerin, M.D. is a hematologist/oncologist and director of the Breast Cancer Treatment and Prevention Program at Overlook Medical Center, Summit, NJ where she also serves as chair of the Breast Panel, the Multidisciplinary Breast Tumor Board and director of Oncology Education. She is the principal investigator of numerous clinical trials exploring new ways to incorporate the latest advances in the management of breast cancer. She is also actively involved in the delivery of highly-specialized immunotherapy, IL-2, for the treatment of melanoma and kidney cancer. As a medical oncologist with more than 20 years of experience, Dr. Guerin is dedicated to providing the most up to date, cutting edge treatment while looking at each of her patients as an individual. Her philosophy is one of collaboration, working with all members of the care team to provide the best outcome possible. Dr. Guerin believes that compassion and being a good listener, traits she learned from her mother, help tailor a treatment plan that reflects not only the highest order of medical care, but also one that uniquely reflects each and every patient. Dr. Guerin believes it is just as much about living well as it is living long. Dr. Guerin earned her M.D. at SUNY Stony Brook in 1988, continued her residency at Vanderbilt University in Nashville and completed her fellowship in oncology/hematology at University of California San Diego Cancer Center. She is board certified in clinical oncology and internal medicine. Since 2002, Dr. Guerin has served as chair of the Women’s Oncology Forum, Network for Oncology Communication and Research (NOCR) – a national organization. She is a diplomate of the American Society of Clinical Oncology (ASCO) and is a recipient of the Pfizer Award for Excellence in Biochemical Research and a Member of the Expert Panel Consensus Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma. She has been named by Castle Connelly as one of NY/Metro Top Doctors for the last 10 years, as well as a Top Doctor for Women's Health. She has recently been honored by Curemonos, a New Jersey non-profit organization dedicated to supporting medically underserved women with breast cancer, was the keynote speaker at the American Cancer Society Relay for Life in Chatham, NJ; and was honored at the Society’s 2019 Diamond Ball, in Woodland Park, NJ. Her interests are in breast cancer, hepatobiliary cancer and immunotherapy.
Dr. Brian Anderson is a Harvard-trained physician-scientist, innovator, and digital health expert. Dr. Anderson’s focus is on the use of information technology in support of emerging clinical decision support (CDS) models and the provision of safe, effective, patient-centered care. While at Athenahealth, where he led the Informatics Department, Dr. Anderson launched a new model of CDS leveraging Artificial Intelligence (AI). He has served on several national health information technology committees in partnership with the Office of the National Coordinator (ONC). At MITRE, Dr. Anderson works on mCODE, a standardized data language and interoperability model for cancer research and treatment, as well as architecting, implementing, and analyzing health information systems for the Centers for Medicare and Medicaid Services (CMS), the Department of Health and Human Services (HHS), and the Department of Veterans Affairs (VA). He also sits on the ONC’s Health Information Technology Advisory Committee. Dr. Anderson has written in the Journal of Precision Medicine and spoken at the Precision Medicine Summit and HIMSS19.
As the founding executive director of UCI’s multidisciplinary Cybersecurity Policy & Research Institute, Bryan Cunningham is focused on solution-oriented strategies that address technical, legal and policy challenges to combat cyber threats; protect individual privacy and civil liberties; maintain public safety, economic and national security; and empower Americans to take better control of their digital security. Cunningham is a leading international expert on cybersecurity law and policy, a former White House lawyer and adviser and a media commentator on cybersecurity, technology and surveillance issues. He has appeared on ABC, Bloomberg, CBS, CNN, FOX and other networks. Cunningham has extensive experience in senior U.S. government intelligence and law enforcement positions. He served as Deputy Legal Adviser to then-National Security Advisor Condoleezza Rice. He also served six years in the Clinton administration as a senior CIA officer and federal prosecutor. He drafted significant portions of the Homeland Security Act and related legislation, helping to shepherd them through Congress. He was a principal contributor to the first National Strategy to Secure Cyberspace, worked closely with the 9/11 Commission and provided legal advice to the President, National Security Advisor, the National Security Council, and other senior government officials on intelligence, terrorism, cyber security and other related matters. Cunningham is a founding partner of the Washington, DC-Los Angeles firm Cunningham Levy Muse, and his law practice has included assisting Fortune 500 and multinational companies to comply with complex legal regulations under U.S. federal law, myriad state laws and the numerous privacy and security requirements in the European Union and other overseas jurisdictions. He was founding vice-chair of the American Bar Association Cyber Security Privacy Task Force and was awarded the National Intelligence Medal of Achievement for his work on information issues. He has served on the National Academy of Sciences Committee on Biodefense Analysis, the Markle Foundation Task Force on National Security in the Information Age and the Bipartisan Policy Center’s Cyber Security Task Force. He is also the principal author of legal and ethics chapters in several cybersecurity textbooks.
Professor of Environmental StudiesBinghamton University, State University of New York
Anthroplogy, Environmental Studies, human population, Cultural Transmission, Remote Sensing, Geophysics
Lipo’s research interests include studying the cultural change of human populations. Lipo uses evolutionary theory as a means of developing methods for studying cultural transmission and the process of natural selection, acting on cultural systems. His work has explored community patterning among prehistoric potters of the Mississippi Valley, patterns of inheritance among stone tools producers in North America and the conditions that led the populations of Easter Island (Rapa Nui, Chili) to construct their famous monumental statues. In addition to the study of artifact variability and geochronology, Lipo has interests in remote sensing, as a means of efficiently and non-destructively studying the archaeological record. This work includes the use of magnetometry, resistivity, conductivity, thermal imagery, photogrammetry, LiDAR and ground penetrating radar.
An assistant professor in the Department of Politics at Ithaca College’s School of Humanities and Sciences, Figueroa can discuss U.S. political issues, including presidential leadership, racial, religious and working class politics, U.S.-Puerto Rico policy, and immigration/border politics. Figueroa’s academic research focuses on American political development; race, religion and citizenship; Black American politics and political thought; Latino politics and border studies; public leadership; and U.S. Quakers. He is currently finishing a book on Quakers, race and U.S. Empire. His research also focuses on Bayard Rustin, a Black, gay, Quaker labor and civil rights activist of the 1940s through 1980s. He is also working on a project about the everyday “lived experiences” of people who study and/or work near the U.S.-Mexico border.
Hedrick received her B.S. in Biology from Salem College in Winston-Salem, North Carolina in 1984. She received her Ph.D. in Biochemistry from Wake Forest University School of Medicine in 1992, where she performed her graduate research on LDL cholesterol metabolism in the laboratory of Dr Lawrence Rudel. From 1992 to 1995, she performed her postdoctoral research on HDL metabolism in the laboratory of Dr Aldons ‘Jake’ Lusis at UCLA. From 1995 to 1999, she worked as a junior faculty member in the Division of Cardiology at UCLA, where her research focused on inflammation and endothelial function. From 2000 to 2009, Dr. Hedrick worked as a professor in the Departments of Pharmacology, Medicine, and Molecular Physiology and Biological Physics at the University of Virginia in Charlottesville. In 2009, Dr. Hedrick was awarded the Harrison Chair of Molecular Physiology and Biological Physics at the University of Virginia. Dr. Hedrick joined the faculty of LJI in the Division of Inflammation Biology in 2009. Dr. Hedrick currently serves on the NHLBI Vascular Cellular Molecular Biology Review Committee, the AAI Committee for the Status of Women, and the American Heart Association ATVB Council Leadership Committee. She is also a Fellow of the American Heart Association. Recent honors received by Dr. Hedrick include the ATVB Vascular Biology Special Recognition Award, from the American Heart Association in 2013; the Jeffrey M. Hoeg Arteriosclerosis Thrombosis and Vascular Biology Award for Basic Science and Clinical Research from the American Heart Association in 2014; and the Arteriosclerosis Thrombosis and Vascular Biology Mentor of Women Award from the American Heart Association in 2015.
Dr. Richardson practices in the Department of Minimally Invasive and Bariatric Surgery at Northwest Hospital and Sinai Hospital, both in Maryland. She completed her fellowship at Northwest Hospital and her residency at Emory University Hospital. She attended medical school at Wake Forest University School of Medicine. Dr. Richardson is also proficient in robotic surgery and general surgery. She also speak French (Canadian) and Spanish.
Cheryl Healton, DrPH, is dean of the College of Global Public Health and professor of public health policy and management at New York University. A public health leader and scholar, Healton has published more than 100 peer-reviewed papers and special reports on topics including HIV/AIDS, the opioid crisis, public health education, health policy, substance abuse, and tobacco. Healton was the founding president and CEO of Legacy (now Truth Initiative), a national foundation dedicated to tobacco control created by the tobacco industry’s Master Settlement Agreement. Healton worked to further the foundation’s mission: to build a world where young people reject tobacco and anyone can quit. During her time with Legacy, Healton guided the national youth tobacco prevention counter-marketing campaign, truth®, which has been credited with reducing youth smoking prevalence to near record lows. Healton is currently focused on what lessons can be learned from the tobacco industry’s Master Settlement Agreement and applied to other public health issues, including opioids, gun violence, obesity, and global warming. https://www.nejm.org/doi/10.1056/NEJMp1802633